Navigation Links
Promising Parkinson's Disease Research Highlighted by The Michael J. Fox Foundation to Accelerate Drug Development
Date:7/11/2013

ased therapeutic potential as it targets both early amyloid assemblies as well as pre-existing aggregates.

Symptomatic Research

  • Cynapsus Therapeutics' development of APL-130277, a novel formulation of the drug apomorphine, as a rescue medication for intermittent OFF episodes in PD. APL-130277 is a thin film strip that dissolves under the tongue.
  • NeuroDerm's clinical research on continuous administration of levodopa and carbidopa through a "pump-patch." This technology could maintain continuous and constant concentration of levodopa in the blood, which should significantly decrease motor fluctuations and possibly reverse dyskinesia.

To date, the Foundation has funded $325 million in research, more than $84 million of which has been directed to over 185 unique projects led by industry partners.

For more information on the MJFF Partnering Program 1H 2013 participants and previously featured grantees, visit https://www.michaeljfox.org/research/opportunities-for-industry/partnering-program.html. The MJFF Research Partnerships team can be reached at ResearchPartnerships@michaeljfox.org.


'/>"/>
SOURCE The Michael J. Fox Foundation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Adult and Adolescent Vaccines Market to 2018 Report - Promising Novel Candidates in Late-Stage Development and Prevnar Approval for Use in Adults to Drive Growth
2. QIAGEN Expands Pipeline of Promising New Biomarkers for Development of Personalized Healthcare Companion Diagnostics
3. Novan Announces Promising Results of SB204 Clinical Study
4. International Mesothelioma Experts Present Promising New Research Findings at the 3rd Annual International Symposium on Lung-Sparing Therapies for Malignant Pleural Mesothelioma
5. Use Of Cryoablation For Treatment Of Breast Cancer Shows Promising Results
6. Statement from the Cystic Fibrosis Foundation on Promising Phase 2 Clinical Trial Results of Kalydeco and VX-661 (Vertex Pharmaceuticals Inc.)
7. University of Michigans Zell Lurie Institute Awards $112,000 to Promising Student Startups in 30th Annual Business Plan Competition and Dare to Dream Grant Program
8. Forbes Ranks SynCardia Among "Americas Most Promising Companies" for Second Straight Year
9. Meth Vaccine Shows Promising Results in Early Tests
10. Epigenetics R&D Pipeline - Histone Deacetylases (HDACs) Offer the Most Promising Targets and Outnumber Other Classes of Epigenetic Targets
11. Boston Scientific Announces Promising Clinical Data on New Products at the International Spine Intervention Society 20th Annual Scientific Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... , 29 luglio 2015 Uno studio ... che l,ingestione quotidiana del probiotico L. reuteri ... e modifica la produzione intestinale di fattori proteici ... la somministrazione quotidiana di ceppo di L. ... compresse utilizzando il sistema di somministrazione brevettato BIO- ...
(Date:7/29/2015)... , July 29, 2015  Cryoport, ... the "Company"), the leading provider of advanced ... industry, serving markets including immunotherapies, stem cells, ... animal health, and reproductive medicine, announced today ... of common stock and warrants (the "Units") under a ...
(Date:7/29/2015)... Colo., July 29, 2015 Heska Corporation ... a provider of advanced veterinary diagnostic and other specialty ... quarter ended June 30, 2015. Second Quarter ... Operations was up nearly 100% to $1.829 million, from $917 ... to $10.1 million, from $7.8 million. , Core Companion ...
Breaking Medicine Technology:È stato clinicamente dimostrato che il probiotico L. reuteri di Nutraceutix regola il metabolismo insulinico intestinale 2Cryoport Completes $6.8 Million Equity Capital Raise 2Cryoport Completes $6.8 Million Equity Capital Raise 3Heska Reports Financial Results for the Second Quarter of 2015 2Heska Reports Financial Results for the Second Quarter of 2015 3Heska Reports Financial Results for the Second Quarter of 2015 4Heska Reports Financial Results for the Second Quarter of 2015 5Heska Reports Financial Results for the Second Quarter of 2015 6Heska Reports Financial Results for the Second Quarter of 2015 7Heska Reports Financial Results for the Second Quarter of 2015 8
... Reportlinker.com announces that a new ... its catalogue: Russian ... (Digital Intraoral X-Ray Systems, Extraoral X-Ray ... http://www.reportlinker.com/p0567538/Russian-Market-for-Dental-Imaging-Equipment-2011-Digital-Intraoral-X-Ray-Systems-Extraoral-X-Ray-Systems-and-CBCT-Scanners.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...
... ,   Ansell Limited ... acquisition of Sandel Medical,Industries, LLC, a recognized leader in ... the US. The Company has,turnover of US$10m p.a. Ansell ... Solutions LLC name. The Sandel product range ...
Cached Medicine Technology:Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) 2Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) 3Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) 4Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) 5Russian Market for Dental Imaging Equipment 2011 (Digital Intraoral X-Ray Systems, Extraoral X-Ray Systems and CBCT Scanners) 6Ansell Limited Acquires Sandel Medical Industries LLC, an Innovator in Surgical Safety Solutions 2
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... of contract manufacturing and packaging services for consumer brands, recently completed a consolidation ... in Baltimore, MD. Previously, the company operated out of two separate locations situated ...
(Date:7/30/2015)... ... July 30, 2015 , ... PeopleKeys, a company with over 30 ... Train the Trainer” webinar. The webinar, the newest installment in their popular DISC for ... The Managing Stress: Train the Trainer webinar is intended for people interested in training ...
(Date:7/30/2015)... ... July 30, 2015 , ... Addictions Training Institute has ... to become Certified Alcohol and Substance Abuse Counselors. , "We are thrilled to be ... is an acute shortage of Alcohol and Drug Counselors nationwide. We are excited ...
(Date:7/29/2015)... ... ... Avid collector, Andrew Hawley from Vintage Rock Posters, announces his search for ... art was used for the Charlotte Coliseum show a month later. According to Hawley, ... style concert posters. , They measure 22 x 28 inches and were printed ...
(Date:7/29/2015)... , ... July 30, 2015 , ... ... for their clients, BOC approved provider of online continuing education courses for ... offerings to their exclusive Andrews Research and Education Sports Medicine Series. , The ...
Breaking Medicine News(10 mins):Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 2Health News:Case Mason Consolidates Operations to Larger Facility for Increased Efficiency, Improved Service 3Health News:PeopleKeys to Air “Managing Stress: Train the Trainer” DISC Webinar 2Health News:Addictions Training Institute Announces New Online Certificate Program for Alcohol and Drug Counselors 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3
... ... one-stop, flat-fee healthcare information technology and support, announced it is bringing ... the hiring of new Chief Healthcare Officer Joel Taylor. Taylor joins ... to practices and medical groups of all scopes and sizes, with ...
... Tuesday, October 13, in response to national calls for an ... announce their "patient-centered" plan for health care reform. The ... policy specialist Art Laffer, will be described in detail, together ... to the press (dial-in information is below). , ...
... ... for Cell Sense in vivo imaging agent , ... Pittsburgh, PA (Vocus) October 12, 2009 -- Celsense, Inc. announced today ... imaging reagent, Cell Sense CS-1000 (Cell Sense). , ,Celsense filed a Drug Master File (a “DMF”) ...
... ... help to otherwise untreatable symptoms of Multiple Sclerosis. , ... Camillo, CA (PRWEB) October 12, 2009 -- , , , ,The ... country a sometimes first in years relief from the relentless progressive symptoms of the disease. ...
... is forming the world,s first national centre for research into ... Arthritis Research Campaign and The University of Nottingham, it will ... cause of chronic pain which affects more than ten ... awarded funding of 2.5m over five years and the University ...
... Oct. 11 Canary Foundation, a nonprofit organization that ... its founder and chairman, Don Listwin, has been elected ... (BSA). Members are appointed to 5-year terms by the ... advice on science program policy, programs and initiatives to ...
Cached Medicine News:Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 2Health News:ITelagen Taps Joel Taylor as Chief Healthcare Officer New Executive to Spearhead EMR Implementations 3Health News:The Obamacare Alternative: 33 State Think Tanks Announce Patient-Centered Health Care Reforms 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 2Health News:Celsense, Inc Files FDA & EMEA Regulatory Submissions 3Health News:People with Multiple Sclerosis are Proactively Improving their Walking, Energy Level, Confidence and Quality of Life 2Health News:People with Multiple Sclerosis are Proactively Improving their Walking, Energy Level, Confidence and Quality of Life 3Health News:National pain research center will bring hope to millions 2Health News:National pain research center will bring hope to millions 3Health News:National pain research center will bring hope to millions 4Health News:Canary Foundation's Don Listwin Appointed to National Cancer Institute's Board of Scientific Advisors 2
ACTH EIA Hypertension / Cardiac Evaluation, Cardiovascular 021-SDX018...
Anti-Gliadin IgG (Ab) EIA Gastrointestinal Markers 027-GD16 Celiac Disease Food Allergy...
... Vitamin D kit is an enzymeimmunoassay for ... hydroxylated metabolites in serum or plasma. Calibrators, ... labelled 25-OH D. The diluted samples are ... with a highly specific sheep 25-OH D ...
EPO EIA Human Cytokines 021-SDX021 Erythropoietin Anemia...
Medicine Products: